Complement Inhibitors Market Global Industry Analysis and Forecast (2024-2032) by Stage of Development (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Age-related Macular Degeneration (AMD), Myasthenia Gravis, Others), Mechanism of Action (C5 Inhibitors, C3 Inhibitors, Terminal Complement Inhibitors, Others), Route of Administration (Intravenous (IV), Subcutaneous (SC)) and Region